FIT Biotech

Our vision

Our mission is to be a globally recognized DNA-vaccine and gene therapy company, through our own research.

Read more

  • Our success

    We measure our success in the value of human life

FIT Biotech aims to make a difference.

R&D Publications

Press release 19.3.2015

Press release 19.3.2015

Novel animal vaccines developed jointly by China and Finland

Read more

Press release, June-16-2014

Press release, June-16-2014

KU Leuven and FIT Biotech demonstrate promise in antibody gene therapy and expand their collaboration to include enzyme replacement treatment.

Read more

RESEARCH & DEVELOPMENT

FIT Biotech’s most important R&D activity since the start of its operations has been the development of an HIV vaccine.

R&D Publications